|
|
Article: Caliper Life Sciences Presents LabChip[R] Platform to the U.S. Food and Drug Administration.
- Article from:
- Vaccine Weekly
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Caliper Life Sciences, Inc. (NASDAQ:CALP), a leading provider of life sciences tools, presented at a training session for reviewers from the United States Food and Drug Administration (FDA) on the benefits of the LabChip GX platform for high throughput screening and characterization assays for biological drugs (see also Regulatory Actions).
"We were pleased to accept the FDA's invitation to present our LabChip platform to a large group of reviewers. We believe the LabChip platform will accelerate the adoption of quality-by-design approaches that ultimately will improve the safety profiles of new biologics and vaccines," said Kevin Hrusovsky, CEO of Caliper Life ...